Peptide Therapeutics Market Growth Forecast at 11% CAGR by 2030
Peptide therapeutics are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases. Rising prevalence of these chronic diseases across the world is further expected to widen the existing patient pool. Therapeutic efficacy of peptide therapeutics is relatively superior as compared to other marketed drugs, resulting in their higher adoption among physicians. The global peptide therapeutics market was valued at US$ 25.6 Bn in 2019, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2020-2030).
The COVID-19 pandemic has been severely affecting the global economic order, and, in turn, the peptide therapeutics market. Restrictions on traveling, self-quarantines, and social distancing regulations, on a national scale, are resulting in notable drop in business and consumer spending through Q2.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1038
“Higher efficacy, widespread availability, and future generic competition are amongst the key factors expected to shape the peptide therapeutics market across the world. With increasing regional product adoption in Asia Pacific (APAC) and the Middle East & Africa (MEA), market players are driving their attention towards these regions for sustained growth.”
Key Takeaways of Peptide Therapeutics Market Study
- In terms revenue generation, among the applications, cancer outperformed other application types, owing to greater prevalence of the disease as well as higher efficacy of peptide therapeutics in cancer treatment.
- Various peptide therapeutics are patented, and, in the mid of this decade, a majority of these patents are expected to reach their expiry dates, leading to higher generic competition.
- Parenteral route continues to hold the leading revenue share in the peptide therapeutics market, owing to effective drug delivery and higher therapeutic index.
Key Players Focus on Strategic Collaborations and Generic Launches to Widen Regional Presence
Leading players in the peptide therapeutics market, such as AstraZeneca plc, Merck Co. & Inc., and Elli Lily, are concentrating on business expansions through joint ventures and distribution agreements, and are capturing untapped market potential.
Additionally, market incumbents are entering into collaborations in order to expand their regional presence and manufacturing capabilities in the global peptide therapeutics market.
For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1038
More Valuable Insights on Peptide Therapeutics Market
Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2015 to 2030. The global peptide therapeutics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the peptide therapeutics market on the basis of application, (cancer, cardiovascular diseases, central nervous systems, metabolic disorders, infection, hematological disorders, gastrointestinal disorders, dermatology, respiratory disorders, acromegaly, and other applications), route of administration (parenteral route, mucosal route, oral route, and transdermal route), and marketing (branded and generic), across seven major regions.
For additional information, write to the analyst at press@futuremarketinsights.com
Explore FMI’s Extensive Coverage on Healthcare Domain
Electronic Stethoscope Market – Global Electronic Stethoscope Market was valued at US$ 170.9 Mn in 2021 and the sales are expected to surpass US$ 259 Mn, increasing by 2.2x between 2022 and 2029
Bone Growth Stimulators Market The global Bone Growth Stimulators Market size is poised to reach US$ 1.8 Bn in 2022.
U.S. Compounding Pharmacies Market U.S. Compounding Pharmacies Market is projected to exceed US$ 4.64 Bn and is expected to grow at over 5.1% CAGR between 2022 and 2028
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/peptide-therapeutics-market
Press Release Source: https://www.futuremarketinsights.com/press-release/peptide-therapeutics-market
